Search results for: 'cards'

Over the last few decades, modernization-driven lifestyle changes have had major implications on people’s health and well-being. Today, chronic health condition such as cardiovascular diseases (CVD) claim more lives than all forms of cancer combined, accounting for 31% of all deaths worldwide. In the United States alone, 800,000 people succumbed to...

This research service analyzes key data and provides an in-depth analysis of the US cardiac ablation market. The segments covered include catheter ablation, surgical ablation, and cardiac mapping. The major topics explored in this study include the most significant products marketed by top participants, cost analysis, competitive playbook, regulato...

30 Sep 2015  |  North America  |  Market Research

Analysis of the Cardiac Biomarker Diagnostics Market

Emerging Biomarkers Disrupt and Spur Growth in the Heart Failure Segment

Infographics

×

The cardiac biomarker diagnostics market is a niche but upcoming space in the United States. With regulations favoring personalized medicine and diagnostics, large companies are focusing their investment in researching and detecting new biomarkers to differentiate their products in this competitive market. In addition to growing prevalence rates th...

20 Jan 2025  |  Global  |  Market Research

Global Cardiac Biomarkers Diagnostics Industry, 2024-2029

Rising Prevalence of CVD and High Sensitivity POCT Driving Transformational Growth in Cardiac Biomarkers Diagnostics

Infographics

×

The global cardiac biomarkers diagnostics market is forecast to record robust growth with the increased prevalence of cardiovascular disease (CVD), multiplex biomarkers, advancements in diagnostic testing technology, higher POCT adoption rates, and an intensive focus on preventive healthcare. CVDs are a leading cause of mortality globally, highligh...

This study highlights emerging companies in the cardiovascular space. Cardiovascular disease detection and monitoring have been gaining significant attention considering rising healthcare costs and challenges related to the availability of a skilled healthcare workforce. Companies are trying to address these challenges with technology-driven so...

Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with cardiac complaints, increasing ED demand for kits that can rapidly rule MI in or out. Both factors serve as signif...

08 Jun 2018  |  North America  |  Market Research

US Cardiac Troponin Diagnostics Market, Forecast to 2021

High Prevalence of Heart Disease Propels Market Growth

Infographics

×

Key Issues Addressed

Cardiac troponins help to diagnose nearly two-thirds of the patients in the diagnosis Acute Coronary Syndrome (ACS) who are missed out by Echocardiogram (ECG). ECG can detect only one-third of the patients with persistent ST-segment Elevation (STEMI), whereas cardiac troponins can distinguish patients without ST-segment elevation (NSTEACS; non-ST s...

Frontline workers are a key part of the workforce in the majority of organizations. Out of approximately two and a half billion non-desk/frontline workers around the world, an estimated one billion require tailored communications and collaboration tools to complete their job tasks. There is no perfect definition of frontline workers. Generally, ...

This research service analyzes the market for ECG and Cardiac Monitoring products and services within the United States. Product markets assessed included Resting ECG Products, Stress Testing Systems, ECG Data Management Systems, Holter Monitor Systems, and Cardiac Event Monitoring Systems. Services markets assessed included Point-of-Care ECG Ser...